BioOrbit

BioOrbit is a UK-based company specializing in the manufacturing of pharmaceuticals in space. The company focuses on the large-scale crystallization of proteins for monoclonal antibodies (mAbs), with the aim of producing more effective cancer drugs.

By leveraging the microgravity environment of space, BioOrbit intends to overcome some of the limitations of Earth-based pharmaceutical manufacturing. The company is preparing for pre-clinical trials in 2026 for protein crystals produced in its planned orbital factory. The primary market for BioOrbit's products is the pharmaceutical industry, which is constantly seeking to develop more effective treatments for a variety of diseases, including cancer.

The company's business model is centered on research and development, with the ultimate goal of commercializing its space-manufactured pharmaceuticals. This involves securing partnerships with pharmaceutical companies and research institutions to further develop and test its products.

Keywords: pharmaceutical manufacturing, space technology, protein crystallization, monoclonal antibodies, cancer drugs, orbital factory, pre-clinical trials, space-based research, drug development, biotechnology.